Get started
Author

Toshiko Miyaki

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
2017 · Miguel Martin, Frankie A Holmes, et al. · The Lancet Oncology · 588
Impact of sentinel lymph node biopsy by ultrasound-guided core needle biopsy for patients with suspicious node positive breast cancer
2017 · Rikiya Nakamura, Naohito Yamamoto, et al. · Breast Cancer · 32
Successful treatment of histiocytic sarcoma with induction chemotherapy consisting of dose-escalated CHOP plus etoposide and upfront consolidation auto-transplantation
2014 · Hideki Tsujimura, Toshiko Miyaki, et al. · International Journal of Hematology · 30
Impact of host and histopathological factors on the discrepancies in estrogen receptor, and progesterone receptor, and HER2 status between core needle biopsy and surgically excised tumors
2015 · Rikiya Nakamura, Naohito Yamamoto, et al. · The Breast · 12
Neratinib After Trastuzumab-Based Adjuvant Therapy in Patients from Asia with Early Stage HER2-Positive Breast Cancer
2019 · Hiroji Iwata, Norikazu Masuda, et al. · Future Oncology · 11
The Clinicopathological and Prognostic Significance of HER2-Low Breast Cancer: A Comparative Analysis Between HER2-Low and HER2-Zero Subtypes
2024 · Reiki Nishimura, Yoshitaka Fujiki, et al. · Clinical Breast Cancer · 9
Efficacy and safety of pegfilgrastim biosimilar MD ‐110 in patients with breast cancer receiving chemotherapy: Single‐arm phase III
2023 · Toshimi Takano, Mitsuya Ito, et al. · Cancer Medicine · 5
Clinical impact of the biology of synchronous axillary lymph node metastases in primary breast cancer on preoperative treatment strategy
2021 · Rikiya Nakamura, Shouko Hayama, et al. · Journal of Surgical Oncology · 5
Abstract P1-13-11: Neratinib in the extended adjuvant treatment of patients from Asia with early-stage HER2+ breast cancer after trastuzumab-based therapy: Exploratory analyses from the phase III ExteNET trial
2018 · H Iwata, N Masuda, et al. · Cancer Research · 3
Synchronous early‑stage breast cancer and axillary follicular lymphoma diagnosed by core needle biopsy: A case report
2021 · Ryotaro Eto, Rikiya Nakamura, et al. · Molecular and Clinical Oncology · 2
PDF
Treatment Strategy for Patients with HR-Positive HER2-Negative Metastatic Breast Cancer That Progressed on CDK4/6 Inhibitors
2021 · Shouko Hayama, Rikiya Nakamura, et al. · Breast Care · 2
PDF
[Administration Order of FEC-DOC in Breast Cancer Adjuvant Chemotherapy Has an Effect on Toxicity].
2015 · Toshiko Miyaki, Hideki Tsujimura, et al. · PubMed · 1
Factors Associated With Non-implementation of Advance Care Planning in Patients With Metastatic Breast Cancer: a Single-institution Retrospective Study
2025 · Toshiko Miyaki, Tetsuhiko Taira, et al. · The Breast
Prognostic Implications of Imaging-based Early Detection of Brain Metastases in Her2-positive Advanced Breast Cancer: a Retrospective Study
2025 · Tetsuhiko Taira, Toshiko Miyaki, et al. · The Breast
Abstract P5-08-19: A novel formula to improve the accuracy of predicting survival time after recurrent breast cancer
2025 · Reiki Nishimura, Yasuaki Sagara, et al. · Clinical Cancer Research
A novel formula to improve the accuracy and prognostic ability of determining the survival time after recurrent breast cancer
2025 · Reiki Nishimura, Yasuaki Sagara, et al. · Breast Cancer
Abstract PO1-24-03: The clinicopathological and prognostic significance of HER2-low breast cancer: A comparative analysis between HER2-low and HER2-zero subtypes
2024 · Reiki Nishimura, Yoshitaka Fujiki, et al. · Cancer Research
MO11-6 Characteristics of patients with pneumocystis pneumonia during cancer chemotherapy enrolled in the institutional serious adverse event database
2023 · Hideki Tsujimura, Sachiko Kamagata, et al. · Annals of Oncology
MO8-5 Pneumocystis jiroveci pneumonia in patients receiving ddAC for breast cancer: A single center retrospective study
2023 · Chika Manako, Rikiya Nakamura, et al. · Annals of Oncology
MO58-5 Abemaciclib-induced liver dysfunction in metastatic breast cancer
2023 · Toshiko Miyaki, Satoshi Yoshimura, et al. · Annals of Oncology
Does Routine Follow-Up after Patients Have Completed Adjuvant Therapy for Early-Stage Breast Cancer at a Cancer Center Improve Prognosis?
2021 · Rikiya Nakamura, Shouko Hayama, et al. · Breast Care
PDF
A phase 2 study evaluating dose dense AC (ddAC) followed by dose dense paclitaxel (ddP) supported by 3.6 mg peg-filgrastim (ddAC-ddP3.6) for patients (pts) with primary breast cancer (PBC) in Japan -WJOG9016B-
2019 · K. Matsumoto, M. Futamura, et al. · The Breast
Abstract P3-03-22: Prognostic impact of axillary lymph node status after neoadjuvant chemotherapy for patients with breast cancer
2019 · R Nakamura, N Yamamoto, et al. · Cancer Research
Impact on disease-free survival (DFS) of the surgical waiting time (SWT) for patients (Pts) with early breast cancer (BC)
2018 · R. Nakamura, N. Yamamoto, et al. · Annals of Oncology
Abstract P3-02-01: Impact of prognoses on the discrepancies in histological grade of breast cancer between core needle biopsy and surgical excision specimen
2018 · R Nakamura, N Yamamoto, et al. · Cancer Research
Works count: 33
Citation count: 700
H-index: 6
I10-index: 5
Year
Topic
Type